Sai Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results
Sai Life Sciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Sai Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results Sai Life Sciences Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26, alongside other corporate matters. In accordance with insider trading regulations, the trading window for dealing in company securities was closed on 1st Oct'26 and will remain closed until 7th Nov'26 (48 hours post-result announcement) for all designated persons and their immediate relatives.
Original exchange filing (PDF)
More announcements from Sai Life Sciences Ltd
- Upgradation in the Credit Rating by India Rating & Research Pvt. Ltd. 路 14 Nov 2026
- Transcripts of Earnings call organized on 06th November 2026 路 12 Nov 2026
- Monitoring Agency Report for the Quarter ended 30th September 2026 路 12 Nov 2026
- Audio Recording of Earnings call for Q-2 FY 2026-27 路 06 Nov 2026
- Investor Presentation on Q-2 FY 2026-27 Financial Results 路 06 Nov 2026
- Press Release on Unaudited Financial Results for the Second Quarter and Half Year Ended 30th September 2026. 路 06 Nov 2026
- Allotment of 1,08,005 Equity having Face Value of Rs.1/- against the options exercised in accordance with the Companies ESOP Plans 路 06 Nov 2026
- Sai Life Sciences Limited has informed the Exchange regarding Allotment of 108005 Shares. 路 06 Nov 2026
